Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Intangibles (2020 - 2025)

Oncology Institute's Intangibles history spans 6 years, with the latest figure at $11.0 million for Q4 2025.

  • For Q4 2025, Intangibles fell 25.62% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, down 25.62%, while the annual FY2025 figure was $11.0 million, 25.62% down from the prior year.
  • Intangibles reached $11.0 million in Q4 2025 per TOI's latest filing, down from $11.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $19.4 million in Q2 2022 to a low of $11.0 million in Q4 2025.
  • Average Intangibles over 5 years is $16.4 million, with a median of $17.2 million recorded in 2023.
  • Peak YoY movement for Intangibles: decreased 0.2% in 2023, then dropped 25.62% in 2025.
  • A 5-year view of Intangibles shows it stood at $18.2 million in 2021, then dropped by 1.58% to $18.0 million in 2022, then fell by 0.3% to $17.9 million in 2023, then fell by 17.28% to $14.8 million in 2024, then fell by 25.62% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Intangibles are $11.0 million (Q4 2025), $11.7 million (Q3 2025), and $12.4 million (Q2 2025).